001     274051
005     20250119000300.0
024 7 _ |a 10.1002/alz.14320
|2 doi
024 7 _ |a pmid:39412000
|2 pmid
024 7 _ |a pmc:PMC11667545
|2 pmc
024 7 _ |a 1552-5260
|2 ISSN
024 7 _ |a 1552-5279
|2 ISSN
024 7 _ |a altmetric:169528155
|2 altmetric
037 _ _ |a DZNE-2025-00032
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Aretz, Benjamin
|0 0000-0003-0143-0873
|b 0
245 _ _ |a The role of leukocytes in cognitive impairment due to long-term exposure to fine particulate matter: A large population-based mediation analysis.
260 _ _ |a Hoboken, NJ
|c 2024
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1736341120_19585
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Our understanding of how fine particulate matter (PM2.5) impacts cognitive functioning is limited. Systemic inflammation processes may play a role in mediating this effect.This prospective cohort study used data from 66,254 participants aged 18+ between 2006 and 2015 from the Dutch Lifelines Cohort Study and Biobank. Causal mediation analysis was conducted to examine the impact of ambient PM2.5 exposure on cognitive processing time (CPT), using the change in white blood cell (WBC) count and its subtypes as potential mediators.Heightened PM2.5 exposure was associated with slower CPT (total effect = 81.76 × 10-3, 95% confidence interval [CI] 59.51 × 10-3-105.31 × 10-3). The effect was partially mediated via increased WBC count (indirect effect [IE] = 0.42 × 10-3, 95% CI 0.07 × 10-3-0.90 × 10-3), particularly driven by an increase in monocytes (IE = 0.73 × 10-3, 95% CI 0.24 × 10-3-1.31 × 10-3).Systemic inflammation processes may partially explain the harmful effects of PM2.5 on cognitive functioning, why lower levels of systemic inflammation may help contain its neurotoxic effects.The pathways leading to the neurotoxic effects of fine particulate matter (PM2.5) are poorly understood. We analyzed data from over 66,000 participants using causal pathway analysis. Increased white blood cell (WBC) count mediates the effect of PM2.5 on cognitive functioning. Monocyte count played a crucial role in this low-pollution setting. Systemic inflammation may contribute to the neurotoxic effects of PM2.5.
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a causal mediation analysis
|2 Other
650 _ 7 |a cognitive functioning
|2 Other
650 _ 7 |a fine particulate matter
|2 Other
650 _ 7 |a leukocytes
|2 Other
650 _ 7 |a systemic inflammation
|2 Other
650 _ 7 |a white blood cell count
|2 Other
650 _ 7 |a Particulate Matter
|2 NLM Chemicals
650 _ 7 |a Air Pollutants
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Particulate Matter: adverse effects
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Cognitive Dysfunction
|2 MeSH
650 _ 2 |a Prospective Studies
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Mediation Analysis
|2 MeSH
650 _ 2 |a Leukocytes: drug effects
|2 MeSH
650 _ 2 |a Environmental Exposure: adverse effects
|2 MeSH
650 _ 2 |a Netherlands: epidemiology
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Inflammation
|2 MeSH
650 _ 2 |a Leukocyte Count
|2 MeSH
650 _ 2 |a Air Pollution: adverse effects
|2 MeSH
650 _ 2 |a Air Pollution: statistics & numerical data
|2 MeSH
650 _ 2 |a Cohort Studies
|2 MeSH
650 _ 2 |a Air Pollutants: adverse effects
|2 MeSH
700 1 _ |a Doblhammer, Gabriele
|0 P:(DE-2719)2811246
|b 1
700 1 _ |a Heneka, Michael
|0 P:(DE-2719)2000008
|b 2
|u dzne
773 _ _ |a 10.1002/alz.14320
|g Vol. 20, no. 12, p. 8715 - 8727
|0 PERI:(DE-600)2201940-6
|n 12
|p 8715 - 8727
|t Alzheimer's and dementia
|v 20
|y 2024
|x 1552-5260
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/274051/files/DZNE-2025-00032.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/274051/files/DZNE-2025-00032.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:274051
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2811246
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 2
|6 P:(DE-2719)2000008
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 0
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-25
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2023-10-25
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0
|0 LIC:(DE-HGF)CCBYNC4
|2 HGFVOC
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2023-10-25
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-25
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-25
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-25
920 1 _ |0 I:(DE-2719)1012002
|k AG Doblhammer
|l Demographic Studies
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1012002
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21